Leap Therapeutics, Inc.

Ownership Transactions Reported by 19 Insiders

Symbol
LPTX on Nasdaq
Industry
Pharmaceutical Preparations
Location
47 Thorndike Street, Suite B1 1, Cambridge, Massachusetts

There are no Buy or Sell transactions made by insiders since 9/11/2023

Leap Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
BeiGene, Ltd. 10%+ Owner $20.9M Sep 24, 2021
Gilead Sciences, Inc. 10%+ Owner $15.2M Apr 10, 2024
Augustine Lawlor Chief Operating Officer $1.94M Jan 29, 2024
Douglas E. Onsi CEO,CFO,Pres.,GC,Treas.,&Sec., Director $1.39M Jan 29, 2024
Christopher Mirabelli Chairman of the Board, Director $1.2M Jan 29, 2024
John Mark O'Mahony Chief Manufacturing Officer $14.3K Jan 29, 2024
Cynthia Sirard Chief Medical Officer $14.3K Jan 29, 2024
Thomas Dietz Director Jan 29, 2024
Joseph Loscalzo Director Jan 29, 2024
Nissim Mashiach Director Jan 29, 2024
Christine Granfield VP, Head of Reg Affairs/Qual Jan 29, 2024
Monica Bertagnolli Director Jan 31, 2022
Perceptive Advisors Llc 10%+ Owner Sep 24, 2021
Richard Schilsky Director Jan 29, 2024
Christian M. Richard Director Jan 29, 2024
Patricia A. Martin Director Jan 29, 2024
Jason Baum Chief Scientific Officer Jan 29, 2024
William Li Director Jan 29, 2024
James Cavanaugh Director Jan 29, 2024

Recent Insider Transactions by Companies or Individuals for Leap Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.